Literature DB >> 11344390

Factors predicting nutritional derangements in patients with obstructive jaundice: multivariate analysis.

F J Padillo1, B Andicoberry, J Muntane, J M Lozano, G Miño, A Sitges-Serra, C Pera-Madrazo.   

Abstract

Patients with obstructive jaundice (OJ) that requires surgery often have malnutrition associated with increased perioperative morbidity. This study investigated the factors influencing nutritional derangements in these patients. A series of 46 OJ patients were investigated prospectively (28 malignant tumors, 18 benign obstructions). A nutritional risk index of < 83.5 was used to define protein-calorie malnutrition. Liver function, cholecystokinin (CCK), tumor necrosis factor-alpha (TNFalpha), and endotoxin levels were determined. A multivariate analysis was performed, and an obstructive jaundice malnutrition index (OJMI) was obtained. Altogether, 22 (48%) OJ patients had malnutrition (33% with benign obstructions, 57% with malignant disease). Malnourished patients had higher serum bilirubin levels (258 +/- 120 vs. 154 +/- 62 mmol/L; p = 0.005), longer duration of jaundice (16 +/- 9 vs. 9 +/- 5 days; p = 0.03), and higher plasma levels of CCK (4.0 +/- 1.3 vs. 1.7 +/- 1.0 pmol/L; p = 0.005), alanine aminotransferase (ALT) (226 +/- 209 vs. 187 +/- 161 UI/L; p = 0.01), endotoxin (15 +/- 10 vs. 6.5 +/- 7.0 EU/L; p = 0.007), and TNFalpha (69 +/- 82 vs. 23 +/- 15 pg/ml; p = 0.008) than those without malnutrition. However, only serum bilirubin, CCK, ALT, and patient age were predictors for malnutrition by multivariate analysis. Malnutrition might be expected (95% confidence interval) in patients older than 68 years with increased bilirubin (> 290 mmol/L) and ALT (> 210 UI/L) levels that corresponded with an OJMI > 55. It was concluded that nutritional alterations in patients with obstructive jaundice were determined by the intensity of the biliary obstruction correlated with increased plasma CCK levels as well as with liver dysfunction and patient age.

Entities:  

Mesh:

Year:  2001        PMID: 11344390     DOI: 10.1007/s002680020043

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  Nutritional risk index as an independent predictive factor for the development of surgical site infection after pancreaticoduodenectomy.

Authors:  Hiroji Shinkawa; Shigekazu Takemura; Takahiro Uenishi; Masayuki Sakae; Kazunori Ohata; Yorihisa Urata; Kazuhisa Kaneda; Akinori Nozawa; Shoji Kubo
Journal:  Surg Today       Date:  2012-09-28       Impact factor: 2.549

Review 2.  Improving outcomes in pancreatic cancer: key points in perioperative management.

Authors:  José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Gut peptide changes in patients with obstructive jaundice undergoing biliary drainage: A prospective case control study.

Authors:  Tajana Pavić; Stipe Pelajić; Nina Blažević; Dominik Kralj; Milan Milošević; Ivana Mikolasevic; Ivan Lerotic; Davor Hrabar
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 4.  Surgery and transplantation - Guidelines on Parenteral Nutrition, Chapter 18.

Authors:  A Weimann; Ch Ebener; S Holland-Cunz; K W Jauch; L Hausser; M Kemen; L Kraehenbuehl; E R Kuse; F Laengle
Journal:  Ger Med Sci       Date:  2009-11-18

Review 5.  Enteral and parenteral nutrition in the perioperative period: state of the art.

Authors:  Salim Abunnaja; Andrea Cuviello; Juan A Sanchez
Journal:  Nutrients       Date:  2013-02-21       Impact factor: 5.717

6.  Oxidative stress influence on renal dysfunction in patients with obstructive jaundice: A case and control prospective study.

Authors:  David Martínez-Cecilia; María Reyes-Díaz; Juan Ruiz-Rabelo; Manuel Gomez-Alvarez; Carmen Muñoz Villanueva; José Álamo; Jordi Muntané; Francisco Javier Padillo
Journal:  Redox Biol       Date:  2015-12-29       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.